ARHGEF10L and acute myeloid leukemia: Based on our experiments, miR‐1294 exerts biological functions through targeting ARHGEF10L, and circFN1 releases ARHGEF10L through chelating miR‐1294, thereby up‐regulating ARHGEF10L level in AML cells.